Tirzepatide is an advanced medication that aids in weight loss and blood sugar control by mimicking two natural hormones to better regulate appetite and blood glucose. Unlike semaglutide, which acts on one hormone, this dual-action treatment offers enhanced support for sustainable weight loss and overall metabolic health.
Tirzepatide is a once-weekly injectable medication designed for weight loss and to help manage blood sugar levels in individuals with type 2 diabetes. It works by mimicking two hormones—GLP-1 and GIP—that help regulate blood sugar, increase insulin sensitivity, and reduce hunger. By targeting both appetite and blood sugar, Tirzepatide can support sustainable weight loss and improved metabolic health when combined with a balanced diet and regular exercise.
Achieve gradual and sustainable weight loss and improved blood sugar control. Optimal results are typically seen after 12-16 weeks of consistent use.
Entire body (weight loss focus).
Bruising and swelling can occur, but will typically subside after a few days. You may apply arnica to help alleviate the bruising.
Bruising and swelling can occur, but will typically subside after a few days. You may apply arnica to help alleviate the bruising.
Bruising and swelling can occur, but will typically subside after a few days. You may apply arnica to help alleviate the bruising.
Reduce body fat and improve overall health with a personalized approach.
Significant progress toward a healthier, more confident you.
Tirzepatide is taken once a week as a subcutaneous injection. Your healthcare provider will guide you on the proper dosage and ensure you follow the schedule for the best results. Consistency with weekly doses is essential for effective progress.
Most patients start seeing weight loss results within the first 4-8 weeks of taking tirzepatide. Clinical studies show that approximately 50-60% of people lose at least 15% of their body weight within 6-12 months when combined with a healthy diet and exercise. Consistency with the treatment is key for achieving significant and lasting results.
Tirzepatide works by targeting two hormones, GIP and GLP-1, while semaglutide only targets GLP-1. This dual-action mechanism may lead to greater weight loss and improved blood sugar control with tirzepatide. Your provider can help determine which option is best for your goals.
Tirzepatide mimics two hormones, GLP-1 and GIP, which help reduce hunger, improve insulin sensitivity, and promote weight loss by increasing feelings of fullness.
Semaglutide is taken once a week as a subcutaneous injection. You will guided on the proper dosage and schedule to ensure optimal results. Regular weekly doses are essential for consistent progress.
Common side effects include nausea, diarrhea, constipation, and abdominal discomfort, which typically improve as your body adjusts to the medication. Rare but serious side effects include pancreatitis, gallbladder issues, or thyroid concerns. If you experience severe or persistent symptoms, contact your healthcare provider immediately.
Schedule a consultation with our expert providers to discuss your aesthetic needs.
Schedule Consult